NEPHROPLUS.NS

HoldPremium Grower

Nephrocare Health Services Limited · Healthcare · India · $744M · Avg Vol: $4M/d

Premium Grower: Strong business with the market behind it, priced at a premium.

55
StockRank
Get score and insider alerts
Quality
69
Value
23
Momentum
57

Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →

P/E (TTM)
77.5x
peers 42.9x
ROE
6.9%
peers 11.9%
D/E
0.1x
peers 0.2x
Dividend %
—
trailing yield

ABOUT NEPHROCARE HEALTH SERVICES LIMITED

Read

Nephrocare Health Services Limited provides dialysis healthcare services through a chain of kidney care clinics and dialysis centers in India, Uzbekistan, Nepal, and the Philippines.

FINANCIAL SUMMARY (INR)

Year2023202420252026CAGRTTM2027E2028EFwd CAGR
Revenue4.1B5.4B7.5B9.9B33.9%10.5B12.1B14.4B20.5%
EPS (INR)-1.173.506.698.4855.6%8.3715.8421.1357.9%
Shares100.3M100.3M100.3M100.3M0.0%100.6M———
Debt2.1B2.7B2.6B797.1M-28.0%796.9M———
Equity3.9B4.1B5.8B11.2B42.2%————
Op CF112.7M722.8M1.4B2.3B174.3%2.4B———
Inv CF-782.1M-506.6M-1.3B-4.1B—————
Fin CF599.7M267.4M543.7M1.6B—————
Loading 1Y...
PRICE (1Y) · INR-3.7%
64967870773676520 Aug10 Sep1 Oct
SMA 50SMA 200

Close
INR 648.95
RSI (14)
11.2

SCORE BREAKDOWN

Quality
69
ROIC
14.1%80.9
ROE
6.9%60.8
GP/Assets
27.4%59.4
Op. Margin
14.0%72.8
FCF/Assets
7.7%80.6
Piotroski
783.9
Int. Cover
3.0x46.4
D/E Ratio
0.07x67.2
Current Ratio
2.80x52.7
Value
23
P/E (TTM)
77.5x12.3
EV/EBITDA
26.9x24.0
P/FCF
62.5x25.8
P/B
5.8x22.5
P/S
6.2x35.5
Div Yield
—N/A
Momentum
57
52W High %
—N/A
RS 6M
23%82.1
SMA 50/200
—N/A
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+152%83.3
Q Growth
35%67.5

FUNDAMENTALS

Market Cap
$744M
P/E (Forward)
30.7x
Gross Margin
38.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NEPHROPLUS.NS are excluded.

TickerCompanyMkt CapStockRankSignal
NEPHROPLUS.NSNephrocare Health Services Limited(you)$744M55Hold
JLHL.NSJupiter Life Line Hospitals Limited$915M51Hold
KOVAI.NSKovai Medical Center and Hospital Limited$696M47Hold
HCG.NSHealthCare Global Enterprises Limited$1.1B57Hold
YATHARTH.NSYatharth Hospital & Trauma Care Services Limited$1.2B71Buy
JSLL.NSJeena Sikho Lifecare Limited$662M78Buy
RAINBOW.NSRainbow Children's Medicare Limited$1.5B66Buy
KMCSHIL.NSKMC Speciality Hospitals (India) Limited$268M48Hold
NH.NSNarayana Hrudayalaya Limited$4.0B60Hold
KIMS.NSKrishna Institute of Medical Sciences Limited$3.5B45Hold

Peer medians: ROE 11.9% · P/E 42.9x · Gross margin 59.4%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Nephrocare Health Services Limited (NEPHROPLUS.NS): Stock Score Summary

Nephrocare Health Services Limited (NEPHROPLUS.NS) has a MoatMap StockRank of 55/100 based on Quality (69/100), Value (23/100), and Momentum (57/100) factor scores. The current signal is HOLD.

Nephrocare Health Services Limited provides dialysis healthcare services through a chain of kidney care clinics and dialysis centers in India, Uzbekistan, Nepal, and the Philippines.

Key Financial Metrics

PriceINR 648.95
Market Cap$744M
P/E (TTM)77.53
P/E (Forward)30.71
Price/Book5.83
Return on Equity6.9%
Return on Invested Capital14.1%
Debt/Equity0.07x
Gross Margin38.8%
Operating Margin14.0%
Revenue Growth23.7%
Free Cash Flow$12M

Nephrocare Health Services Limited operates in the Medical Care Facilities industry, part of the Healthcare sector (India).

Frequently Asked Questions

What is Nephrocare Health Services Limited’s (NEPHROPLUS.NS) StockRank?
MoatMap’s StockRank for Nephrocare Health Services Limited (NEPHROPLUS.NS) is 55/100, with a Hold signal. It is a composite of Quality (69), Value (23), and Momentum (57) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Nephrocare Health Services Limited have an economic moat?
Nephrocare Health Services Limited (NEPHROPLUS.NS) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Nephrocare Health Services Limited a buy, hold, or sell?
MoatMap’s current signal for Nephrocare Health Services Limited (NEPHROPLUS.NS) is Hold, based on a StockRank of 55/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Nephrocare Health Services Limited in?
Nephrocare Health Services Limited (NEPHROPLUS.NS) operates in the Healthcare sector, specifically the Medical Care Facilities industry (India).